Opioid Litigation's Growing Strength: From Snowflakes To Blizzard
Executive Summary
Infographic examines key opioid events since Purdue's 2007 settlement as legal actions snowball to include disclosures by DEA and wholesalers as well.
You may also be interested in...
Opioid Litigation: Drug Mfrs. Lose Bid To Limit Data Disclosure; First Trials Set For March
US court orders firms to release information on all opioid products ever classified as Schedule II from one year prior to launch date; government, manufacturers oppose public disclosure of DEA distribution data.
Opioid Litigation: Court Asks US FDA To Attend Education Session
Judge overseeing multidistrict litigation convenes meeting with senior pharma executives, government plaintiffs and others to learn about supply-chain dynamics and other issues to resolve more than 200 suits.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.